doi:10.48130/targetome-0026-0013

[1]

Li S, Zhang B, Jiang D, Wei Y, Zhang N. 2010. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 11:S6

doi: 10.1186/1471-2105-11-S11-S6

[2]

Tang J, Aittokallio T. 2014. Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles. Current Pharmaceutical Design 20:23−36

doi: 10.2174/13816128113199990470

[3]

Huang C, Zheng C, Li Y, Wang Y, Lu A, et al. 2014. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Briefings in Bioinformatics 15:710−733

doi: 10.1093/bib/bbt035

[4]

Chen A, Zhu X, Jiang H, Gong M, Cui S, et al. 2025. Combination of silybin and carvedilol synergistically alleviates liver fibrosis by inhibiting Wnt/β-catenin signaling. Targetome 1:e009

doi: 10.48130/targetome-0025-0009

[5]

Li W, Wang K, Liu Y, Wu H, He Y, et al. 2022. A novel drug combination of mangiferin and cinnamic acid alleviates rheumatoid arthritis by inhibiting TLR4/NFκB/NLRP3 activation-induced pyroptosis. Frontiers in Immunology 13:912933

doi: 10.3389/fimmu.2022.912933

[6]

Li H, Xie YH, Yang Q, Wang SW, Zhang BL, et al. 2012. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. PLoS One 7:e48872

doi: 10.1371/journal.pone.0048872

[7]

Hu J, Gao J, Fang X, Liu Z, Wang F, et al. 2022. DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations. Briefings in Bioinformatics 23:bbac302

doi: 10.1093/bib/bbac302

[8]

Li H, Zou L, Kowah JAH, He D, Wang L, et al. 2023. Predicting drug synergy and discovering new drug combinations based on a graph autoencoder and convolutional neural network. Interdisciplinary Sciences: Computational Life Sciences 15:316−330

doi: 10.1007/s12539-023-00558-y

[9]

Liu Q, Xie L. 2021. TranSynergy: mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations. PLoS Computational Biology 17:e1008653

doi: 10.1371/journal.pcbi.1008653

[10]

Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, et al. 2015. Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science 347:1257601

doi: 10.4135/9781412994170.n162

[11]

Cheng F, Kovács IA, Barabási AL. 2019. Network-based prediction of drug combinations. Nature Communications 10:1197

doi: 10.1038/s41467-019-09186-x

[12]

Cheng F, Desai RJ, Handy DE, Wang R, Schneeweiss S, et al. 2018. Network-based approach to prediction and population-based validation of in silico drug repurposing. Nature Communications 9:2691

doi: 10.1038/s41467-018-05116-5

[13]

Guney E, Menche J, Vidal M, Barábasi AL. 2016. Network-based in silico drug efficacy screening. Nature Communications 7:10331

doi: 10.1038/ncomms10331

[14]

Wang Y, Yang H, Chen L, Jafari M, Tang J. 2021. Network-based modeling of herb combinations in traditional Chinese medicine. Briefings in Bioinformatics 22:bbab106

doi: 10.1093/bib/bbab106

[15]

Liu P, Huang F, Zheng X, Hao H. 2025. Targetome-guided combination drug discovery as next-generation therapeutics. Targetome 1:e002

doi: 10.48130/targetome-0025-0002

[16]

Gan X, Shu Z, Wang X, Yan D, Li J, et al. 2023. Network medicine framework reveals generic herb-symptom effectiveness of traditional Chinese medicine. Science Advances 9:eadh0215

doi: 10.1126/sciadv.adh0215

[17]

Tian S, Xu M, Geng X, Fang J, Xu H, et al. 2025. Network medicine-based strategy identifies maprotiline as a repurposable drug by inhibiting PD-L1 expression via targeting SPOP in cancer. Advanced Science 12:e2410285

doi: 10.1002/advs.202410285

[18]

Dai Z, Hu T, Wei J, Wang X, Cai C, et al. 2024. Network-based identification and mechanism exploration of active ingredients against Alzheimer's disease via targeting endoplasmic reticulum stress from traditional chinese medicine. Computational and Structural Biotechnology Journal 23:506−519

doi: 10.1016/j.csbj.2023.12.017

[19]

Liu J, Wu Q, Wu Q, Zhong G, Liang Y, et al. 2023. Modulating endoplasmic reticulum stress in APP/PS1 mice by Gomisin B and Osthole in Bushen-Yizhi formula: synergistic effects and therapeutic implications for Alzheimer's disease. Phytomedicine 119:155023

doi: 10.1016/j.phymed.2023.155023

[20]

Corrao WM, Braman SS, Irwin RS. 1979. Chronic cough as the sole presenting manifestation of bronchial asthma. New England Journal of Medicine 300:633−637

doi: 10.1056/NEJM197903223001201

[21]

Rybka-Fraczek A, Dabrowska M, Grabczak EM, Bialek-Gosk K, Klimowicz K, et al. 2021. Does bronchial hyperresponsiveness predict a diagnosis of cough variant asthma in adults with chronic cough: a cohort study. Respiratory Research 22:252

doi: 10.1186/s12931-021-01845-2

[22]

Diab N, Patel M, O'Byrne P, Satia I. 2022. Narrative review of the mechanisms and treatment of cough in asthma, cough variant asthma, and non-asthmatic eosinophilic bronchitis. Lung 200:707−716

doi: 10.1007/s00408-022-00575-6

[23]

Antoniu SA, Mihaescu T, Donner CF. 2007. Pharmacotherapy of cough-variant asthma. Expert Opinion on Pharmacotherapy 8:3021−3028

doi: 10.1517/14656566.8.17.3021

[24]

Côté A, Russell RJ, Boulet LP, Gibson PG, Lai K, et al. 2020. Managing chronic cough due to asthma and NAEB in adults and adolescents: CHEST Guideline and Expert Panel Report. Chest 158:68−96

doi: 10.1016/j.chest.2019.12.021

[25]

Heffler E, Madeira LNG, Ferrando M, Puggioni F, Racca F, et al. 2018. Inhaled corticosteroids safety and adverse effects in patients with asthma. The Journal of Allergy and Clinical Immunology: In Practice 6:776−781

doi: 10.1016/j.jaip.2018.01.025

[26]

Qin W, Wu X, Jia Y, Tong X, Guo C, et al. 2019. Suhuang antitussive capsule inhibits NLRP3 inflammasome activation and ameliorates pulmonary dysfunction via suppression of endoplasmic reticulum stress in cough variant asthma. Biomedicine & Pharmacotherapy 118:109188

doi: 10.1016/j.biopha.2019.109188

[27]

Nguyen V, Zhang Q, Pan F, Jin Q, Sun M, et al. 2023. Zi-Su-Zi decoction improves airway hyperresponsiveness in cough-variant asthma rat model through PI3K/AKT1/mTOR, JAK2/STAT3 and HIF-1α/NF-κB signaling pathways. Journal of Ethnopharmacology 314:116637

doi: 10.1016/j.jep.2023.116637

[28]

Sun Y, Han Y, Guo W, Xu X, Zhao L, et al. 2024. Multi-omics analysis of lung tissue metabolome and proteome reveals the therapeutic effect of Shegan Mahuang Decoction against asthma in rats. Journal of Ethnopharmacology 322:117650

doi: 10.1016/j.jep.2023.117650

[29]

Wen L, Zhang T, Chen F, Hu L, Dou C, et al. 2023. Modified Dingchuan Decoction treats cough-variant asthma by suppressing lung inflammation and regulating the lung microbiota. Journal of Ethnopharmacology 306:116171

doi: 10.1016/j.jep.2023.116171

[30]

Liu Z, Wu X, Si Z, Kong D, Yang D, et al. 2021. Simultaneous determination of nine constituents by validated UFLC-MS/MS in the plasma of cough variant asthma rats and its application to pharmacokinetic study after oral administration of Huanglong cough oral liquid. Journal of Pharmaceutical and Biomedical Analysis 193:113726

doi: 10.1016/j.jpba.2020.113726

[31]

Xu HY, Zhang YQ, Liu ZM, Chen T, Lv CY, et al. 2019. ETCM: an encyclopaedia of traditional Chinese medicine. Nucleic Acids Research 47:D976−D982

doi: 10.1093/nar/gky987

[32]

Wu Y, Zhang F, Yang K, Fang S, Bu D, et al. 2019. SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping. Nucleic Acids Research 47:D1110−D1117

doi: 10.1093/nar/gky1021

[33]

Ji ZL, Zhou H, Wang JF, Han LY, Zheng CJ, et al. 2006. Traditional Chinese medicine information database. Journal of Ethnopharmacology 103:501

doi: 10.1016/j.jep.2005.11.003

[34]

Ru J, Li P, Wang J, Zhou W, Li B, et al. 2014. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics 6:13

doi: 10.1186/1758-2946-6-13

[35]

Huang L, Xie D, Yu Y, Liu H, Shi Y, et al. 2018. TCMID 2.0: a comprehensive resource for TCM. Nucleic Acids Research 46:D1117−D1120

doi: 10.1093/nar/gkx1028

[36]

Zhang RZ, Yu SJ, Bai H, Ning K. 2017. TCM-Mesh: the database and analytical system for network pharmacology analysis for TCM preparations. Scientific Reports 7:2821

doi: 10.1038/s41598-017-03039-7

[37]

Kim SK, Lee MK, Jang H, Lee JJ, Lee S, et al. 2024. TM-MC 2.0: an enhanced chemical database of medicinal materials in Northeast Asian traditional medicine. BMC Complementary Medicine and Therapies 24:40

doi: 10.1186/s12906-023-04331-y

[38]

Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, et al. 2016. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Research 44:D380−D384

doi: 10.1093/nar/gkv1277

[39]

Wang Y, Sui Y, Yao J, Jiang H, Tian Q, et al. 2024. Herb-CMap: a multimodal fusion framework for deciphering the mechanisms of action in traditional Chinese medicine using Suhuang antitussive capsule as a case study. Briefings in Bioinformatics 25:bbae362

doi: 10.1093/bib/bbae362

[40]

Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, et al. 2023. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Research 51:D638−D646

doi: 10.1093/nar/gkac1000

[41]

Qin W, Tong X, Liang R, Tang K, Wu X, et al. 2021. Preservation of mitochondrial homeostasis is responsible for the ameliorative effects of Suhuang antitussive capsule on non-resolving inflammation via inhibition of NF-κB signaling and NLRP3 inflammasome activation. Journal of Ethnopharmacology 271:113827

doi: 10.1016/j.jep.2021.113827

[42]

Jiang H, Bai Z, Ou Y, Liu H, Si Z, et al. 2023. β-Hydroxybutyric acid upregulated by Suhuang antitussive capsule ameliorates cough variant asthma through GSK3β/AMPK-Nrf2 signal axis. Journal of Ethnopharmacology 307:116013

doi: 10.1016/j.jep.2022.116013

[43]

Zhao ZY, Jiang H, Ou YY, Chen XY, Wu N, et al. 2024. Ameliorative effects of praeruptorin A from Suhuang antitussive capsules on cough variant asthma. Chinese Traditional Patent Medicine 46:2904−2914

doi: 10.3969/j.issn.1001-1528.2024.09.010

[44]

O'Hayre M, Salanga CL, Handel TM, Allen SJ. 2008. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochemical Journal 409:635−649

doi: 10.1042/BJ20071493

[45]

Prendergast CE, Morton MF, Figueroa KW, Wu X, Shankley NP. 2006. Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice. British Journal of Pharmacology 147:886−896

doi: 10.1038/sj.bjp.0706677

[46]

Prakash YS. 2013. Airway smooth muscle in airway reactivity and remodeling: what have we learned? American Journal of Physiology-Lung Cellular and Molecular Physiology 305:L912−L933

doi: 10.1152/ajplung.00259.2013

[47]

Postma DS, Kerstjens HA. 1998. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 158:S187−S192

doi: 10.1164/ajrccm.158.supplement_2.13tac170

[48]

Chen XX, Zhang JH, Pan BH, Ren HL, Feng XL, et al. 2016. TRPC3-mediated Ca²⁺ entry contributes to mouse airway smooth muscle cell proliferation induced by lipopolysaccharide. Cell Calcium 60:273−281

doi: 10.1016/j.ceca.2016.06.005

[49]

Cao X. 2016. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nature Reviews Immunology 16:35−50

doi: 10.1038/nri.2015.8

[50]

Rahiminejad S, Maurya MR, Subramaniam S. 2019. Topological and functional comparison of community detection algorithms in biological networks. BMC Bioinformatics 20:212

doi: 10.1186/s12859-019-2746-0

[51]

Yang S, Zhao X, Yv X, Xie Y, Wang L. 2023. Complex network analysis of elemene injection combined with drugs in the treatment of bone-based metastatic tumors on louvain clustering algorithm in real world. Pharmacology and Clinics of Chinese Materia Medica 39:75−79

doi: 10.13412/j.cnki.zyyl.20221102.001

[52]

Sokulsky LA, Garcia-Netto K, Nguyen TH, Girkin JLN, Collison A, et al. 2020. A critical role for the CXCL3/CXCL5/CXCR2 neutrophilic chemotactic axis in the regulation of type 2 responses in a model of rhinoviral-induced asthma exacerbation. The Journal of Immunology 205:2468−2478

doi: 10.4049/jimmunol.1901350

[53]

Al-Alwan LA, Chang Y, Mogas A, Halayko AJ, Baglole CJ, et al. 2013. Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration. The Journal of Immunology 191:2731−2741

doi: 10.4049/jimmunol.1203421

[54]

Qu L, Fu K, Yang J, Shimada SG, LaMotte RH. 2015. CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis. Pain 156:1737−1746

doi: 10.1097/j.pain.0000000000000208

[55]

Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, et al. 2001. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. The Journal of Pathology 194:398−405

doi: 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S

[56]

Wendell SG, Fan H, Zhang C. 2020. G protein-coupled receptors in asthma therapy: pharmacology and drug action. Pharmacological Reviews 72:1−49

doi: 10.1124/pr.118.016899

[57]

Nayak AP, Penn RB. 2020. The proton-sensing receptor ovarian cancer G-protein coupled receptor 1 (OGR1) in airway physiology and disease. Current Opinion in Pharmacology 51:1−10

doi: 10.1016/j.coph.2020.03.004

[58]

Du X, Li F, Zhang C, Li N, Huang H, et al. 2021. Eosinophil-derived chemokine (hCCL15/23, mCCL6) interacts with CCR1 to promote eosinophilic airway inflammation. Signal Transduction and Targeted Therapy 6:91

doi: 10.1038/s41392-021-00482-x

[59]

Lambrecht BN, Hammad H, Fahy JV. 2019. The cytokines of asthma. Immunity 50:975−991

doi: 10.1016/j.immuni.2019.03.018

[60]

Qin Z, Tang R, Liang J, Jia X. 2024. Berberine, a natural alkaloid: advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseases. International Immunopharmacology 137:112422

doi: 10.1016/j.intimp.2024.112422

[61]

Gendrisch F, Esser PR, Schempp CM, Wölfle U. 2021. Luteolin as a modulator of skin aging and inflammation. BioFactors 47:170−180

doi: 10.1002/biof.1699

[62]

Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, et al. 2019. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics 9:1923−1951

doi: 10.7150/thno.30787

[63]

Ji L, Su S, Xin M, Zhang Z, Nan X, et al. 2022. Luteolin ameliorates hypoxia-induced pulmonary hypertension via regulating HIF-2α-Arg-NO axis and PI3K-AKT-eNOS-NO signaling pathway. Phytomedicine 104:154329

doi: 10.1016/j.phymed.2022.154329

[64]

Zhu Y, Ouyang Z, Du H, Wang M, Wang J, et al. 2022. New opportunities and challenges of natural products research: when target identification meets single-cell multiomics. Acta Pharmaceutica Sinica B 12:4011−4039

doi: 10.1016/j.apsb.2022.08.022

[65]

Imran M, Rauf A, Abu-Izneid T, Nadeem M, Ali Shariati M, et al. 2019. Luteolin, a flavonoid, as an anticancer agent: a review. Biomedicine & Pharmacotherapy 112:108612

doi: 10.1016/j.biopha.2019.108612

[66]

Zhu C, Li K, Peng XX, Yao TJ, Wang ZY, et al. 2022. Berberine a traditional Chinese drug repurposing: its actions in inflammation-associated ulcerative colitis and cancer therapy. Frontiers in Immunology 13:1083788

doi: 10.3389/fimmu.2022.1083788

[67]

Dong Y, Fan H, Zhang Z, Jiang F, Li M, et al. 2022. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway. International Journal of Biological Sciences 18:1381−1397

doi: 10.7150/ijbs.65476

[68]

Habtemariam S. 2020. Berberine pharmacology and the gut microbiota: a hidden therapeutic link. Pharmacological Research 155:104722

doi: 10.1016/j.phrs.2020.104722

[69]

Zhang S, Xu P, Zhu Z, Zhou L, Li J, et al. 2023. Acetylation of p65^Lys310 by p300 in macrophages mediates anti-inflammatory property of berberine. Redox Biology 62:102704

doi: 10.1016/j.redox.2023.102704

[70]

Zhu M, Sun Y, Su Y, Guan W, Wang Y, et al. 2024. Luteolin: a promising multifunctional natural flavonoid for human diseases. Phytotherapy Research 38:3417−3443

doi: 10.1002/ptr.8217

[71]

Kou JJ, Shi JZ, He YY, Hao JJ, Zhang HY, et al. 2022. Luteolin alleviates cognitive impairment in Alzheimer's disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation. Acta Pharmacologica Sinica 43:840−849

doi: 10.1038/s41401-021-00702-8

[72]

Xue L, Jin X, Ji T, Li R, Zhuge X, et al. 2023. Luteolin ameliorates DSS-induced colitis in mice via suppressing macrophage activation and chemotaxis. International Immunopharmacology 124:110996

doi: 10.1016/j.intimp.2023.110996

[73]

Shan W, Xu J, Assaraf YG. 2026. Data-driven targetome discovery and database requirements: insights from the therapeutic target database. Targetome 2:e003

doi: 10.48130/targetome-0026-0001

[74]

Liu Z, Du J, Yan X, Zhong J, Cui L, et al. 2018. TCMAnalyzer: a chemo- and bioinformatics web service for analyzing traditional Chinese medicine. Journal of Chemical Information and Modeling 58:550−555

doi: 10.1021/acs.jcim.7b00549

[75]

Kong X, Liu C, Zhang Z, Cheng M, Mei Z, et al. 2024. BATMAN-TCM 2.0: an enhanced integrative database for known and predicted interactions between traditional Chinese medicine ingredients and target proteins. Nucleic Acids Research 52:D1110−D1120

doi: 10.1093/nar/gkad926